Folate Receptor Targeting Mn(II) Complex Encapsulated Porous Silica Nanoparticle as an MRI Contrast Agent for...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Radiology

Background:

• Cancer is a leading cause of mortality, with early detection significantly improving survival rates.
• Folate receptors are overexpressed on cancer cells, making them a target for diagnostic and therapeutic strategies.
• Developing advanced contrast agents for Magnetic Resonance Imaging (MRI) is crucial for early cancer diagnosis.

Purpose of the Study:

• To develop and characterize a novel porous silica nanoparticle system (C1@SiO2-FA-NP) for early-stage cancer detection.
• To evaluate the potential of C1@SiO2-FA-NP as a T1-weighted MRI contrast agent.
• To confirm the targeted delivery and enhanced cellular uptake of the nanoparticles in cancer cells.

Main Methods:

• Synthesis of porous silica nanoparticles impregnated with a Mn(II) complex and functionalized with folate units.
• Measurement of longitudinal relaxivity (r1) values under physiological conditions.
• In vitro cellular uptake studies using fluorescently labeled nanoparticles (FITC) in cancer (HeLa) and healthy (HEK293) cells.
• In vivo MRI studies in C57BL/6 mice bearing HeLa tumors.

Main Results:

• The C1@SiO2-FA-NP system demonstrated a high longitudinal relaxivity (r1 = 21.45 mM-1s-1), which increased significantly in the presence of Bovine Serum Albumin (BSA).
• Fluorescent imaging confirmed exclusive uptake of the nanoparticles by cancerous HeLa cells compared to healthy HEK293 cells, highlighting the role of folate functionalization.
• In vivo studies established the applicability of C1@SiO2-FA-NP as a T1-weighted MRI contrast agent for early-stage cancer diagnosis in a mouse model.

Conclusions:

• The developed C1@SiO2-FA-NP nanoparticles show excellent potential as targeted MRI contrast agents for early cancer detection.
• Folate functionalization is critical for the selective accumulation of nanoparticles in cancer cells.
• This nanoparticle system offers a promising platform for improving the sensitivity and specificity of cancer diagnosis via MRI.